# Juno Therapeutics, Inc.: Form D filings

Juno Therapeutics, Inc., a biotechnology company in Seattle, WA, filed 7 Form D notices with the SEC between 2013 and 2017. The latest, on October 5, 2017, reports $31.1 million sold of a $31.1 million offering to 1 investor.

Find out what Juno Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Juno%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Juno%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fjuno-therapeutics-inc-1594864)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Juno%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Juno%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fjuno-therapeutics-inc-1594864)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Washington](https://specstream.ai/data/form-d/state/washington): 1,095 rows, by operating companies, filed since November 1, 2024, $54.75, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/washington
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 400 DEXTER AVENUE NORTH, SUITE 1200, Seattle, WA, 98109
- Phone: (206) 582-1600
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2013
- Revenue range: $25,000,001 - $100,000,000
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1594864

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 5, 2017 | New notice | $31,091,407 | $31,091,407 | $0 | 1 | Sep 26, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1594864/000159486417000036/0001594864-17-000036-index.htm) |
| Jun 29, 2017 | Amendment | Indefinite | $898,495,324 | Indefinite | 2 | Jun 29, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1594864/000159486417000029/0001594864-17-000029-index.htm) |
| Jul 6, 2016 | Amendment | Indefinite | $896,803,493 | Indefinite | 2 | Jun 29, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1594864/000159486416000002/0001594864-16-000002-index.htm) |
| Jul 14, 2015 | New notice | Indefinite | $849,803,496 | Indefinite | 1 | Jun 29, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1594864/000159486415000001/0001594864-15-000001-index.htm) |
| Aug 14, 2014 | New notice | $133,734,641 | $85,499,985 | $48,234,656 | 22 | Aug 1, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1594864/000159486414000002/0001594864-14-000002-index.htm) |
| May 8, 2014 | New notice | $97,000,000 | $28,423,971 | $68,576,029 | 34 | Apr 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1594864/000159486414000001/0001594864-14-000001-index.htm) |
| Dec 26, 2013 | New notice | $7,145,909 | $6,667,672 | $478,237 | 21 | Dec 13, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1594864/000159486413000001/0001594864-13-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Mary Agnes Wilderotter | Director |  |
| Hal J. Barron | Director |  |
| Richard J. Klausner | Director, Promoter |  |
| Anthony J. Evnin | Director |  |
| Robert J. Nelsen | Director, Promoter |  |
| Sunil Agarwal | Executive Officer |  |
| Steven Harr | Executive Officer |  |
| Robert Azelby | Executive Officer |  |
| Thomas Agnes Daniel | Director |  |
| Howard J. Pien | Director |  |
| Hans Bishop | Executive Officer, Director, Promoter |  |
| Bernard J. Cassidy | Executive Officer |  |
| Rupert Agnes Vessey | Director |  |
| Jay J. Flatley | Director |  |

## Other biotechnology companies in Washington that filed recently

- [Key Proteo, Inc.](https://specstream.ai/data/form-d/company/key-proteo-inc-1977784) $2.3 million · Oct 23, 2026
- [Inmedix, Inc.](https://specstream.ai/data/form-d/company/inmedix-inc-1851853) $4 million · Oct 22, 2026
- [Q-Immune, Inc.](https://specstream.ai/data/form-d/company/q-immune-inc-2155816) $25,000 · Sep 28, 2026
- [Hexamer Therapeutics, Inc](https://specstream.ai/data/form-d/company/hexamer-therapeutics-inc-1797915) $500,000 · Sep 15, 2026
- [MalarVx, Inc.](https://specstream.ai/data/form-d/company/malarvx-inc-1559688) $125,000 · Aug 25, 2026
- [Strella Biotechnology, Inc.](https://specstream.ai/data/form-d/company/strella-biotechnology-inc-1810011) $1.8 million · Aug 14, 2026

[Every Form D from the week of Oct 2, 2017](https://specstream.ai/data/form-d/week/2017-10-02) · [All recent filings in Washington](https://specstream.ai/data/form-d/state/washington) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Juno Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).